When ovarian cancer is diagnosed, the standard medical pathway often involves removing both ovaries and the uterus along with the fallopian tubes. This surgical combination eliminates the possibility of carrying a pregnancy in the future. Egg freezing as a fertility-preserving option is rarely pursued because the preparation required to stimulate ovarian function, followed by egg retrieval and rapid freezing, can delay cancer treatment. This perspective comes from leading clinicians at SM-Clinic, including Doctor of Medical Sciences Professor Alexander Seryakov, who spoke with socialbites.ca.
Professor Seryakov notes that removing both ovaries and the uterus eliminates the capacity for pregnancy. Cryopreservation of eggs in ovarian cancer patients is infrequent since it depends on hormonal stimulation to mature several follicles. The process typically lasts at least two weeks, after which eggs are collected, frozen, and stored. In the context of a cancer diagnosis, the priority is swift treatment to save the patient’s life rather than pursue fertility preservation.
Given these considerations, women with a family history of ovarian cancer should monitor their health closely and engage in proactive screening and discussions with their medical team.
Seryakov emphasizes that regular gynecological checkups, whether part of routine health care or a formal screening program, are as essential as daily dental care for maintaining reproductive health and overall well-being.
Historically, some American oncology guidelines noted the removal of the fallopian tubes during pelvic surgeries for patients who do not plan to have children, aimed at reducing the risk of ovarian cancer. The concern is that many tumors may originate in the tubes. For a broader understanding of how Russian experts view this measure, related material from socialbites.ca provides additional context.
In summary, the medical approach to ovarian cancer often centers on immediate treatment and disease control. Fertility preservation options are nuanced and time-sensitive, and decisions are tailored to the patient’s overall health, cancer stage, and future reproductive goals. These considerations underscore the need for comprehensive counseling and multidisciplinary care to help patients balance life expectancy with potential fertility desires. This information reflects the views of SM-Clinic’s leadership and the evolving international discussions on ovarian cancer management, as reported by health commentators and clinical specialists.